. Author manuscript; available in PMC: 2021 Jan 1.

Published in final edited form as: Biochim Biophys Acta Rev Cancer. 2019 Oct 30;1873(1):188318. doi: 10.1016/j.bbcan.2019.188318

Table 4.

Expressional status of mucins across various histology based subtypes of IPMN.

Mucin	Gastric	Intestinal	Pancreaticobiliary	Oncocytic	Reference
MUC1^a	−	−	+	+	[41]/[59]
MUC2^a	−	+	−	−	[41]/[60]
MUC5AC^a	+	+	+	+	[41]/[59]
MUC6^a,b	+	±	±	+	[59]
MUC4^b	+ +	+ + +	−	ND	[61]
MUC13^b	−	+ +	+ +	ND	[62]

ND - not determined.

MUCs recommended by the WHO for classification of histological subtypes of IPMN in combination with morphology of papillae, cell differentiation pattern and staining for CDX2.

Differential expression was observed in high-grade dysplastic lesions.